Kam Lawrence

Q4 2019 13F Holdings

  • Location
    honolulu, HI
  • Num holdings

    7

  • Value ($000)

    $97,381

  • Date Filed
    02/13/2020
  • Form type
    13F-HR
  • CIK
    0001802765
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2019 to
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
ADVM
ADVM

ADVERUM BIOTECHNOLOGIES INC

COM
00773U108
$46.58M
48 %

4,043,212

RGNX
RGNX

REGENXBIO INC

COM
75901B107
$19.08M
20 %

465,664

SRPT
SRPT

SAREPTA THERAPEUTICS INC

COM
803607100
$14.54M
15 %

112,689

GNW
GNW

GENWORTH FINL INC

COM CL A
37247D106
$9.23M
10 %

2,097,335

FRX
FRX

FENNEC PHARMACEUTICALS INC

COM
31447P100
$5.42M
6 %

834,689

---

THIRD PT REINS LTD

COM
G8827U100
$2.39M
3 %

227,185

---

TRONOX HOLDINGS PLC

SHS
G9087Q102
$149.00K
0 %

13,055

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 7 of 7